Journal
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
Volume 35, Issue 1, Pages 74-102Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/13102818.2020.1847683
Keywords
Coronaviruses; SARS-CoV-2; COVID-19; model systems; therapeutical agents; vaccines
Categories
Funding
- Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences
- Slovenian Research Agency (ARRS) [P1-0201, P20046]
Ask authors/readers for more resources
SARS-CoV-2, an emerging human beta-coronavirus, has caused the COVID-19 pandemic, with a wide range of symptoms affecting various systems in the body. Many infected individuals are asymptomatic or have mild symptoms, but a significant proportion require hospitalization and a small percentage can become critically ill. This review provides a comprehensive summary on the virus biology, pathological manifestations, immune response, experimental models, treatment options, and vaccine strategies.
SARS-CoV-2 is an emerging human beta-coronavirus that caused the COVID-19 (Coronavirus Disease - 19) pandemic, the most significant health and social crisis in the last 100 years. SARS-CoV-2 is not only a respiratory virus; the symptoms of COVID-19 can include gastrointestinal, neurological, renal, cardiovascular and other complications. A large part of SARS-CoV-2 infected individuals are asymptomatic or have mild symptoms, around 20% of COVID-19 cases require hospitalization, and 5% can become critically ill. This review summarizes data on the biology of the virus and its pathological manifestations, antiviral immune response, information on the experimental models used in the related studies, treatment approaches and vaccine strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available